Check out our next-generation stem cell (iPSCs)- & CRISPR-based approach to treat dystrophic epidermolysis bullosa. Hot off the press: nature.com/articles/s4146…
#cellandgenetherapy #regenerativemedicine #genomeengineering #DEBRA #CIRM
#cellandgenetherapy #regenerativemedicine #genomeengineering #DEBRA #CIRM